Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block listing Return

1 Jul 2021 11:35

RNS Number : 8637D
Oxford Biomedica PLC
01 July 2021
 

For Immediate Release

01 July 2021

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

01 Jan 2021

To:

30 June 2021

Balance of unallotted securities under scheme(s) from previous return:

213,198

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

150,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

106,654

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

256,544

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

01 Jan 2021

To:

30 June 2021

Balance of unallotted securities under scheme(s) from previous return:

179,760

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

200,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

121,292

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

258,468

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

01 Jan 2021

To:

30 June 2021

Balance of unallotted securities under scheme(s) from previous return:

155,679

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

100,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

28,791

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

226,888

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

01 Jan 2021

To:

30 June 2021

Balance of unallotted securities under scheme(s) from previous return:

240,351

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

150,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

14,482

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

375,869

 

 

 

Name of contact:

Natalie Walter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRRBMMTMTJMBJB
Date   Source Headline
13th Sep 20163:07 pmRNSPublication of Prospectus
13th Sep 20167:01 amRNSFUNDRAISING OF £10 MILLION
13th Sep 20167:00 amRNSINTERIM RESULTS FOR 6 MONTHS ENDED 30 JUNE 2016
1st Sep 201610:47 amRNSTotal Voting Rights
25th Aug 20162:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20164:35 pmRNSPrice Monitoring Extension
2nd Aug 20169:32 amRNSTotal Voting Rights
28th Jul 20167:00 amRNSManufacturing Approvals and Expansion Completed
25th Jul 20169:56 amRNSDirector/PDMR Shareholding
8th Jul 201612:02 pmRNSPrice Monitoring Extension
4th Jul 20169:14 amRNSBlock Listing Return
4th Jul 20169:12 amRNSTotal Voting Rights
28th Jun 20164:40 pmRNSSecond Price Monitoring Extn
28th Jun 20164:35 pmRNSSecond Price Monitoring Extn
28th Jun 201612:07 pmRNSSecond Price Monitoring Extn
28th Jun 201612:02 pmRNSPrice Monitoring Extension
27th Jun 201610:37 amRNSDirector/PDMR Shareholding
22nd Jun 201612:07 pmRNSSecond Price Monitoring Extn
22nd Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 20164:40 pmRNSSecond Price Monitoring Extn
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 201612:07 pmRNSSecond Price Monitoring Extn
15th Jun 201612:02 pmRNSPrice Monitoring Extension
7th Jun 20161:14 pmRNSOxford BioMedica Annual General Meeting
7th Jun 20167:00 amRNSNew Non-Exclusive LentiVector Licence with MolMed
6th Jun 20163:29 pmRNSOXB to Present at Jefferies Healthcare Conference
2nd Jun 201610:05 amRNSR&D Partnership with Green Cross LabCell
2nd Jun 20169:30 amRNSTotal Voting Rights
24th May 201610:08 amRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSDeferred Bonus Plan and LTIP Option Grants
17th May 20167:00 amRNSOxford BioMedica Appoints Corporate Broker
16th May 20169:23 amRNSDirector/PDMR Shareholding
16th May 20169:16 amRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSOxford BioMedica Board Change
6th May 201612:21 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSLong-Term Expression of LentiVector
5th May 20165:50 pmRNS2015 Annual Report and Accounts & AGM Notification
5th May 20169:22 amRNSDirector/PDMR Shareholding
4th May 20168:48 amRNSDirector/PDMR Shareholding
3rd May 201612:57 pmRNSDirector/PDMR Shareholding
3rd May 20169:25 amRNSTotal Voting Rights
29th Apr 20161:35 pmRNSDirector Shareholding
28th Apr 20167:00 amRNSPreliminary Results for the Year Ended 31 Dec 2015
26th Apr 20167:00 amRNSStuart Henderson Appointed as a NED
25th Apr 20168:48 amRNSDirector/PDMR Shareholding
15th Apr 20168:50 amRNSHolding(s) in Company
1st Apr 20169:01 amRNSTotal Voting Rights
24th Mar 20169:27 amRNSDirector Dealings
11th Mar 20164:28 pmRNSHolding(s) in Company
7th Mar 20167:00 amRNSImmune Design Collaboration and Licence Expanded

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.